|

|
|
|
|
| Singapore |
| S$25 M Healthy Longevity Institute and global brain health collaboration to advance healthy ageing in Singapore |

Nanyang Technological University, Singapore (NTU Singapore), NHG Health and the Geriatric Education and Research Institu...Read more
- 08 October 2026 News
|
|
| Japan |
| Japan's Shionogi continues rare disease expansion with acquisition of IntraBio for $2 B |

Japan-based Shionogi & Co. is entering into an agreement to acquire IntraBio Inc, a biopharmaceutical company develo...Read more
- 08 October 2026 News
|
|
|
|
|
| China |
| China's XtalPi debuts Kodexia™ as world's first closed-loop siRNA platform |

|
China's XtalPi Holdings, an AI and robotics-driven drug and materials discovery company, has debuted Kodexia™, the...Read more
- 08 October 2026 News
|
|
| Cell & Gene |
| Korea's GC Cell and Israel-based QuantHealth collaborate to optimise clinical cevelopment of cell therapy product |

|
South Korea-based GC Cell, a leader in the cell and gene therapy (CGT) sector within the biopharmaceutical industry, and...Read more
- 08 October 2026 News
|
|
|
|
|
|
| North America |
| GE HealthCare buys SOFIE Biosciences for $945 M to establish 'Final Mile' footprint for PET Radiopharmaceutical Supply in US |

|
GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences, a leading US-based CMO for PET radiopha...Read more
- 08 October 2026 News
|
|
|
|
|
All you want to read on
|

|
|
This email has been sent to you in association with
www.biospectrumasia.com
Tell Us What You Think! Help us improve our newsletters. Send us your feedback!
© Copyright 2026 MM ACTIV. All rights reserved.
To Unsubscribe click here.
Disclaimer : Please remember – by opting-in you are still able to opt-out at any time, by simply replying to this email at digital@mmactiv.com and typing 'unsubscribe' in the 'subject' field of any future emails. We promise only to send emails that we believe you will find interesting, relevant and current. Your data will never be sold or shared with any third party, although we may communicate a message to you from a partner that we are in collaboration with.
|
|
|